3 completed, 1 enrolling by invitation. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Enrolling by invitation 1 |
Follow Pituitary ACTH Hypersecretion: new trials by email Literature Review of Pituitary ACTH Hypersecretion trials Research Report on Pituitary ACTH Hypersecretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Osilodrostat and Cabergoline in Cushing's Disease osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion | Phase 4 | Enrolling by invitation | University of Basrah | 50 | 2026-05-11 | 2026-05-22 |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Pasireotide s.c., Sitagliptin, Liraglutide - Cushing's Disease, Acromegaly | Phase 4 | Completed | Novartis Pharmaceuticals | 249 | 2014-05-23 | 2019-05-29 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment Pasireotide 0.6 MG/ML - Cushing Disease | Phase 4 | Completed | University of Palermo | 24 | 2013-05-01 | 2017-10-27 |
Acromegaly (2) · Adrenal Insufficiency (1) · Dumping Syndrome (1) · Hyperandrogenism (1) · Hyperglycemia (1) · Hypertension (1) · Hypokalemia (1) · Melanoma (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Pituitary Neoplasms (1) · Prostatic Neoplasms (1)
Brain Diseases (4) · Central Nervous System Diseases (4) · Endocrine System Diseases (4) · Hyperpituitarism (4) · Hypothalamic Diseases (4) · Nervous System Diseases (4) · Pituitary Diseases (4) · Bone Diseases (2) · Bone Diseases, Endocrine (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Urogenital Diseases (2) · 46, XX Disorders of Sex Development (1)
pasireotide (3) · Cabergoline (2) · Insulin (1) · Liraglutide (1) · Metformin (1) · Osilodrostat (1) · Sitagliptin Phosphate (1)
Novartis Pharmaceuticals (1) · RECORDATI GROUP (1) · University of Basrah (1) · University of Palermo (1)
Belgium (2) · Brazil (2) · Germany (2) · India (2) · Peru (2) · Poland (2) · Russia (2) · Thailand (2) · Turkey (Türkiye) (2) · United States (2) · Argentina (1) · Bulgaria (1) · Canada (1) · China (1) · Denmark (1)
Abbas A Mansour (1) · Haider A Alidrisi (1) · Ibrahim H Hussein, MD (1)